The Journal of antimicrobial chemotherapy

Keyphrases

Publications

volume 78, number 3, 2023

Chris E Pinto Jimenez, Maddy Pearson, Mathew Hennessey, Esin Nkereuwem, Chloe Crocker, Uzoamaka Egbujo, Jolijn Hendriks, Sarah Smith, Phakha Whanpuch, Rachel Manongi, Ngo Thi Hoa, Clare I R Chandler
Awareness of antibiotic resistance: a tool for measurement among human and animal health care professionals in LMICs and UMICs. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Adeola Y Olukosi, Olusola Ajibaye, Omowunmi Omoniwa, Olusola Oresanya, Aina O Oluwagbemiga, Chinazo Ujuju, Michael Ekholuenetale, Kolawole Maxwell, Colin J Sutherland, James K Tibenderana, Khalid B Beshir
Baseline prevalence of molecular marker of sulfadoxine/pyrimethamine resistance in Ebonyi and Osun states, Nigeria: amplicon deep sequencing of dhps-540. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Kamilia Abdelraouf, Yasmeen Abouelhassan
In vivo pharmacokinetic/pharmacodynamic evaluation of cefepime/taniborbactam combination against cefepime-non-susceptible Enterobacterales and Pseudomonas aeruginosa in a murine pneumonia model. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Maria Ruiz-Ruigomez, Elena Rubio Martín, Pilar Vizcarra, Francisco Braojos Sánchez, Álvaro Diaz Gago, Laura Del Campo Albendea, Alfonso Muriel, Ana Verónica Halperin, Manuel Ponce Alonso, Santiago Moreno, Javier Cobo
Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence of Clostridioides difficile infection: a propensity score analysis. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Luiza H Galarion, Jennifer K Mitchell, Christopher P Randall, Alex J O'Neill
An extensively validated whole-cell biosensor for specific, sensitive and high-throughput detection of antibacterial inhibitors targeting cell-wall biosynthesis. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Bianca B P Antunes, Amanda A B Silva, Patricia H C Nunes, Ignacio Martin-Loeches, Pedro Kurtz, Silvio Hamacher, Fernando A Bozza
Antimicrobial consumption and drug utilization patterns among COVID-19 and non-COVID-19 patients. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Suraj Balakrishna, Tom Loosli, Maryam Zaheri, Paul Frischknecht, Michael Huber, Katharina Kusejko, Sabine Yerly, Karoline Leuzinger, Matthieu Perreau, Alban Ramette, Chris Wymant, Christophe Fraser, Paul Kellam, Astrid Gall, Hans H Hirsch, Marcel Stoeckle, Andri Rauch, Matthias Cavassini, Enos Bernasconi, Julia Notter, Alexandra Calmy, Huldrych F Gunthard, Karin J Metzner, Roger D Kouyos
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Salomé Abdellaoui, Matthieu Gregoire, Marie Dubert, Geoffrey Cheminet, Jean-Benoît Arlet, Emmanuel Lafont
Suboptimal dalbavancin dosages in an adult with sickle-cell disease and glomerular hyperfiltration. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Elaine Cristina Francisco, Chendo Dieleman, Ferry Hagen, Arnaldo Lopes Colombo, null null
In vitro activity of isavuconazole against clinically relevant Trichosporon species: a comparative evaluation of EUCAST broth microdilution and MIC Test Strip methods. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Meng-Ying Pi, Chang-Jie Cai, Ling-Yun Zuo, Jun-Tao Zheng, Miao-Lun Zhang, Xiao-Bin Lin, Xiao Chen, Guo-Ping Zhong, Yan-Zhe Xia
Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Jianxin Hu, Lin Chen, Guihua Li, Yu Pan, Yixing Lu, Jin Chen, Wenguang Xiong, Zhenling Zeng
Prevalence and genetic characteristics of fosB-positive Staphylococcus aureus in duck farms in Guangdong, China in 2020. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Theresa Maria Wagner, Benjamin Peter Howden, Arnfinn Sundsfjord, Kristin Hegstad
Transiently silent acquired antimicrobial resistance: an emerging challenge in susceptibility testing. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Chris E Pinto Jimenez, Maddy Pearson, Mathew Hennessey, Esin Nkereuwem, Chloe Crocker, Uzoamaka Egbujo, Jolijn Hendriks, Sarah Smith, Phakha Whanpuch, Rachel Manongi, Ngo Thi Hoa, Clare I R Chandler
Awareness of antibiotic resistance: a tool for measurement among human and animal health care professionals in LMICs and UMICs. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Liang Chen, Jie Hua, Shu-Jie Hong, Chen-Yang Yuan, Ruo-Chen Jing, Xuan-Yu Luo, Hao-Wen Xue, Yue Yue, Xiao-Pu He
Comparison of the relative efficacy of β-lactam/β-lactamase inhibitors and carbapenems in the treatment of complicated urinary tract infections caused by ceftriaxone-non-susceptible Enterobacterales: a multicentre retrospective observational cohort study. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Sihem Benaboud, Caroline Solas, Stephane Bouchet, Matthieu Gregoire, Florian Lemaitre, Nicolas Venisse, Minh Patrick Lê, Patrice Muret, Francois Parant, Nadege Neant, Sana Boujafaar, Jennifer Lagoutte-Renosi, Rodolphe Garraffo, Gilles Peytavin
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Theresa Maria Wagner, Benjamin Peter Howden, Arnfinn Sundsfjord, Kristin Hegstad
Transiently silent acquired antimicrobial resistance: an emerging challenge in susceptibility testing. The Journal of antimicrobial chemotherapy 78 (3) (2023)
E Gallois, Vincent Fihman, M Danjean, C Gomart, H Kimseng, R Le Guen, G Royer, P L Woerther
QMAC-dRAST for the direct testing of antibiotic susceptibility for Enterobacterales in positive blood-culture broth: a comparison of the performances with the MicroScan system and direct disc diffusion testing methods. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Camilla Nordheim Solli, Magnus Bock, Kamal P Kaur, Jonas H Kristensen, Eva Greibe, Henrik P Hansen, Lene Boesby, Rikke Borg, Mavish Chaudry, Elke Hoffmann-Lücke, Claus E Moser, Alexander C Falkentoft, Emil Loldrup Fosboel, Lauge Østergaard, Christian Torp-Pedersen, Henning Bundgaard, Kasper Karmark Iversen, Niels E Bruun
Plasma concentration of orally administered amoxicillin and clindamycin in patients receiving haemodialysis. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Adeola Y Olukosi, Olusola Ajibaye, Omowunmi Omoniwa, Olusola Oresanya, Aina O Oluwagbemiga, Chinazo Ujuju, Michael Ekholuenetale, Kolawole Maxwell, Colin J Sutherland, James K Tibenderana, Khalid B Beshir
Baseline prevalence of molecular marker of sulfadoxine/pyrimethamine resistance in Ebonyi and Osun states, Nigeria: amplicon deep sequencing of dhps-540. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Jasmina Al Janabi, Staffan Tevell, Raphael Niklaus Sieber, Marc Stegger, Bo Söderquist
Emerging resistance in Staphylococcus epidermidis during dalbavancin exposure: a case report and in vitro analysis of isolates from prosthetic joint infections. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Tomefa E Asempa, Joseph L Kuti, Jeffrey C Nascimento, Samuel J Pope, Edward L Salerno, Patrick J Troy, Yasmeen Abouelhassan
Bronchopulmonary disposition of IV cefepime/taniborbactam (2-0.5 g) administered over 2 h in healthy adult subjects. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Sandra McCurdy, Stephanie A Halasohoris, Ashley L Babyak, Sanae Lembirik, Randall Hoover, Mark Hickman, Jennifer Scarff, Christopher P Klimko, Christopher K Cote, J Matthew Meinig
Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracis. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Wright W Nichols, Sushmita D Lahiri, Patricia A Bradford, Gregory G Stone
The primary pharmacology of ceftazidime/avibactam: resistance in vitro. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Chandra Datta Sumi, Jason Alexander Roberts, Fekade Bruck Sime
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae-authors' response. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Aart van der Meijden, Vincent Aranzana-Climent, Heleen van der Spek, Brenda C M de Winter, William Couet, Joseph Meletiadis, Anouk E Muller, Sanne van den Berg
Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Wright W Nichols, Sushmita D Lahiri, Patricia A Bradford, Gregory G Stone
The primary pharmacology of ceftazidime/avibactam: resistance in vitro. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Zhao-Hui Ding, Yu Huang, Jin-Nan Chen, Lai-Sheng Luo, Wei Zhang, Xiao Liang, Hong Lu
A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Christopher Robson, Bryan Tan, Rhonda Stuart, Stephen Nicholls, Benjamin A Rogers, Indy Sandaradura
A systematic review of optimal pharmacokinetic/pharmacodynamic parameters for beta-lactam therapy in infective endocarditis. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Nadim Cassir, Marie Jumpertz
Subcutaneously administered antibiotics: a review (addendum). The Journal of antimicrobial chemotherapy 78 (3) (2023)
Sophie Grabar, Valérie Potard, Lionel Piroth, Sophie Abgrall, Louis Bernard, Clotilde Allavena, Fabienne Caby, Pierre de Truchis, Claudine Duvivier, Patricia Enel, Christine Katlama, Marie-Aude Khuong, Odile Launay, Sophie Matheron, Giovanna Melica, Hugues Melliez, Jean-Luc Meynard, Juliette Pavie, Laurence Slama, Sylvie Bregigeon, Pierre Tattevin, Jacqueline Capeau, Dominique Costagliola
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Maria Ruiz-Ruigomez, Elena Rubio Martín, Pilar Vizcarra, Francisco Braojos Sánchez, Álvaro Diaz Gago, Laura Del Campo Albendea, Alfonso Muriel, Ana Verónica Halperin, Manuel Ponce Alonso, Santiago Moreno, Javier Cobo
Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence of Clostridioides difficile infection: a propensity score analysis. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Ximin Zeng, Atsushi Hinenoya, Ziqiang Guan, Fuzhou Xu, Jun Lin
Critical role of the RpoE stress response pathway in polymyxin resistance of Escherichia coli. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Xin-Xin Li, Fen-Qiang Zhang, Shuang Wang, Xiao-Chao Duan, Da-Yue Hu, Dong-Yang Gao, Pan Tao, Xiang-Min Li, Ping Qian
Streptococcus suis prophage lysin as a new strategy for combating streptococci-induced mastitis and Streptococcus suis infection. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Kamilia Abdelraouf, Yasmeen Abouelhassan
In vivo pharmacokinetic/pharmacodynamic evaluation of cefepime/taniborbactam combination against cefepime-non-susceptible Enterobacterales and Pseudomonas aeruginosa in a murine pneumonia model. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Antoine Bachelard, Valentina Isernia, Charlotte Charpentier, Aida Benalycherif, Marion Mora, Cécile Donadille, Claudine Duvivier, Karine Lacombe, Mayssam El Mouhebb, Bruno Spire, Roland Landman, Diane Descamps, Gilles Peytavin, Lambert Assoumou, Jade Ghosn, null null
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Camilla Nordheim Solli, Magnus Bock, Kamal P Kaur, Jonas H Kristensen, Eva Greibe, Henrik P Hansen, Lene Boesby, Rikke Borg, Mavish Chaudry, Elke Hoffmann-Lücke, Claus E Moser, Alexander C Falkentoft, Emil Loldrup Fosboel, Lauge Østergaard, Christian Torp-Pedersen, Henning Bundgaard, Kasper Karmark Iversen, Niels E Bruun
Plasma concentration of orally administered amoxicillin and clindamycin in patients receiving haemodialysis. The Journal of antimicrobial chemotherapy 78 (3) (2023)

volume 78, number 6, 2023

Daniele Armenia, Maria M Santoro, Charlotte Charpentier, Ada Bertoli, Federica Forbici, Vincent Calvez, Diane Descamps, Francesca Ceccherini-Silberstein, Anne-Genevieve Marcelin, Philippe Flandre
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings. The Journal of antimicrobial chemotherapy 78 (6) (2023)

The Journal of antimicrobial chemotherapy

Keyphrases

Publications

volume 78, number 3, 2023

volume 78, number 6, 2023

volume 78, number 9, 2023

volume 78, number Supplement_1, 2023

volume 78, number Supplement_2, 2023